Sale!

TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TPP1 gene, associated with Spinocerebellar Ataxia Type 7 (SCA7), is a critical marker for this autosomal recessive genetic disorder. SCA7 is a progressive, neurodegenerative condition characterized by a loss of coordination, affecting movements and balance due to cerebellar ataxia. The condition can also lead to vision loss and other systemic symptoms. The genetic test for TPP1 gene mutations offers a definitive diagnosis, enabling early intervention and management strategies for affected individuals and their families.

At DNA Labs UAE, a specialized genetic test targeting the TPP1 gene linked to Spinocerebellar Ataxia Type 7 is available. This test is crucial for individuals with a family history of SCA7 or those exhibiting symptoms suggestive of the condition. The test is performed using a sample of the individual’s blood or saliva, utilizing advanced genetic sequencing technologies to detect mutations in the TPP1 gene.

The cost of the TPP1 gene test for Spinocerebellar Ataxia Type 7 at DNA Labs UAE is 4400 AED. This price encompasses the comprehensive analysis required to identify any genetic abnormalities within the TPP1 gene. Given the complexity and the specialized nature of this genetic test, the cost reflects the extensive resources, including state-of-the-art technology and expert geneticists, necessary to provide accurate and reliable results.

By opting for this test at DNA Labs UAE, individuals gain crucial insights into their genetic makeup, empowering them with the information needed to make informed health and lifestyle decisions. Additionally, this testing can aid in the genetic counseling process, offering families a clearer understanding of their genetic heritage and the risks of transmitting the condition to future generations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test

Welcome to DNA Labs UAE, your trusted genetic testing laboratory. Today, we will be discussing the TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test.

Test Name: TPP1 Gene Spinocerebellar Ataxia Type 7 Autosomal Recessive Genetic Test

Components

  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Neurological Disorders

Doctor

Neurologist

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for TPP1 Gene Spinocerebellar Ataxia Type 7, autosomal recessive NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TPP1 Gene Spinocerebellar Ataxia Type 7, autosomal recessive.

Test Details

The TPP1 gene is associated with a condition called spinocerebellar ataxia type 7 (SCA7). SCA7 is a progressive neurodegenerative disorder that affects the cerebellum, a part of the brain involved in coordinating movement. Autosomal recessive inheritance means that both copies of the TPP1 gene must be mutated in order for the condition to develop. This means that an individual must inherit a mutated copy of the gene from both parents in order to be affected by SCA7.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the TPP1 gene, to identify any mutations or variations that may be present. This type of testing can help confirm a diagnosis of SCA7 and can also be used for carrier testing in individuals with a family history of the condition.

Overall, the TPP1 gene spinocerebellar ataxia type 7 autosomal recessive NGS genetic test is a genetic test that analyzes the TPP1 gene for mutations associated with autosomal recessive SCA7 using next-generation sequencing technology.

Test Name TPP1 Gene Spinocerebellar ataxia type 7 autosomal recessive Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TPP1 Gene Spinocerebellar ataxia type 7, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with TPP1 Gene Spinocerebellar ataxia type 7, autosomal recessive
Test Details

The TPP1 gene is associated with a condition called spinocerebellar ataxia type 7 (SCA7). SCA7 is a progressive neurodegenerative disorder that affects the cerebellum, a part of the brain involved in coordinating movement.

Autosomal recessive inheritance means that both copies of the TPP1 gene must be mutated in order for the condition to develop. This means that an individual must inherit a mutated copy of the gene from both parents in order to be affected by SCA7.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes, including the TPP1 gene, to identify any mutations or variations that may be present. This type of testing can help confirm a diagnosis of SCA7 and can also be used for carrier testing in individuals with a family history of the condition.

Overall, the TPP1 gene spinocerebellar ataxia type 7 autosomal recessive NGS genetic test is a genetic test that analyzes the TPP1 gene for mutations associated with autosomal recessive SCA7 using next-generation sequencing technology.